Vivani Medical Inc. (VANI)
NASDAQ: VANI
· Real-Time Price · USD
1.26
-0.01 (-0.79%)
At close: Aug 15, 2025, 2:57 PM
Vivani Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 398K | n/a | n/a | n/a | 518K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 260.00 | n/a | n/a | n/a |
Cost of Revenue | n/a | 102K | n/a | 112K | 100K | 99K | 98K | 71K | 80K | 108K | 110K | 261K | 11K | n/a | 130.00 | n/a | n/a | n/a |
Gross Profit | n/a | -102K | 199K | -112K | -100K | -99K | 420K | -71K | -80K | -108K | -110K | -261K | -11K | n/a | 130.00 | n/a | n/a | n/a |
Operating Income | -7.46M | -6.56M | -6.46M | -6.31M | -5.68M | -6.23M | -6.22M | -7.14M | -7M | -6.6M | -7.79M | -5.44M | -4.09M | -3.91M | -3.55M | -3.48M | -2.3M | -2.98M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | n/a |
Pretax Income | -7.14M | -6.3M | -6.05M | -6.04M | -5.36M | -6.04M | -6.03M | -6.78M | -6.53M | -6.32M | -7.28M | 1.42M | -4.1M | -3.92M | -3.62M | -3.49M | -2.29M | -2.99M |
Net Income | -7.14M | -6.3M | -6.05M | -6.04M | -5.36M | -6.04M | -6.03M | -6.78M | -6.53M | -6.04M | -6.8M | 8.29M | -4.12M | -3.94M | -3.62M | -3.49M | -2.29M | -2.99M |
Selling & General & Admin | 2.7M | 2.34M | 2.16M | 2.11M | 2.17M | 2.4M | 1.41M | 2.7M | 3.14M | 2.65M | 3.36M | 1.58M | 884K | 1.23M | 573K | 617K | 1.34M | 569K |
Research & Development | 4.76M | 4.22M | 4.3M | 4.2M | 3.51M | 3.73M | 4.71M | 4.44M | 3.86M | 3.96M | 4.43M | 3.85M | 3.2M | 2.68M | 2.98M | 2.87M | 695K | 2.41M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 99K | 98K | n/a | 477K | 283K | -4K | 4K | -16K | -17K | n/a | -6K | 263K | -12K |
Operating Expenses | 7.46M | 6.56M | 6.46M | 6.31M | 5.68M | 6.23M | 6.22M | 7.14M | 7M | 6.6M | 7.79M | 5.44M | 4.09M | 3.91M | 3.55M | 3.48M | 2.3M | 2.98M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -99K | -98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.46M | 6.56M | 6.46M | 6.31M | 5.68M | 6.23M | 6.22M | 7.14M | 7M | 6.6M | 7.79M | 5.44M | 4.09M | 3.91M | 3.55M | 3.48M | 2.3M | 2.98M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -42.09K | -283K | -485K | -6.87M | 16K | 17K | n/a | -18K | 2K | n/a |
Shares Outstanding (Basic) | 59.24M | 59.24M | 57.42M | 55.25M | 55.02M | 52.2M | 51.02M | 50.84M | 50.8M | 50.76M | 50.74M | 37.97M | 50.73M | 33.09M | 39.41M | 33.09M | 28.67M | 33.09M |
Shares Outstanding (Diluted) | 59.24M | 59.24M | 57.42M | 55.25M | 55.02M | 52.2M | 51.02M | 50.84M | 50.8M | 50.76M | 50.74M | 38.48M | 50.73M | 33.09M | 39.41M | 33.09M | 28.67M | 33.09M |
EPS (Basic) | -0.12 | -0.11 | -0.11 | -0.11 | -0.1 | -0.12 | -0.12 | -0.13 | -0.13 | -0.12 | -0.13 | 0.22 | -0.08 | -0.12 | -0.09 | -0.11 | -0.08 | -0.09 |
EPS (Diluted) | -0.12 | -0.11 | -0.11 | -0.11 | -0.1 | -0.12 | -0.12 | -0.13 | -0.13 | -0.12 | -0.13 | 0.22 | -0.08 | -0.12 | -0.09 | -0.11 | -0.08 | -0.09 |
EBITDA | -7.46M | -6.46M | -6.37M | -6.2M | -5.58M | -6.13M | -6.12M | -7.07M | -6.92M | -6.49M | -8.07M | -5.34M | -4M | -3.82M | -3.46M | -3.4M | -2.28M | -2.89M |
EBIT | -7.14M | -6.56M | -6.46M | -6.31M | -5.68M | -6.23M | -6.22M | -7.14M | -7M | -6.6M | -7.28M | -5.44M | -4.09M | -3.91M | -3.55M | -3.48M | -2.29M | -2.98M |
Depreciation & Amortization | n/a | 102K | 89K | 112K | 100K | 99K | 98K | 71K | 80K | 108K | 110K | 261K | 87K | 83K | 83K | 18K | 19K | 88K |